Status:
COMPLETED
National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups
Lead Sponsor:
AstraZeneca
Conditions:
Coronary Patients
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this observational study is to compare frequency of attainment control goals through the more represented cardiovascular factor risk, dyslipidemia, among coronary patients with or witho...
Eligibility Criteria
Inclusion
- patient with coronary disease diagnosed since at least 1 year
- Echocardiography done less than 1 year ago
- patient with or without documented heart failure
Exclusion
- None
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
1650 Patients enrolled
Trial Details
Trial ID
NCT00699959
Start Date
June 1 2008
End Date
January 1 2009
Last Update
August 6 2009
Active Locations (324)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Abbeville, France
2
Research Site
Aix-en-Provence, France
3
Research Site
Aix-les-Bains, France
4
Research Site
Ajaccio, France